Can Clover Health Double Your Money?
Shares of Clover Health (NASDAQ: CLOV) have lost about half of their value since Chamath Palihapitiya's special acquisition company took it public just a few months ago. Despite a few months of lousy performance, enthusiasm for the digital health upstart is still going strong on Wall Street. Bank of America recently reiterated its buy rating on the stock with a $15 price target that suggests it could double your money.
A new direct contracting program from the Centers for Medicare and Medicaid Services (CMS) inspired Bank of America analyst Kevin Fischbeck to make such a bold call. Could he be right, or is this just a flash in the pan?
Image source: Getty Images.
Source Fool.com
